Biomm reports 172% revenue growth and Rede Soma wins pharmacy award

Biomm reported a significant financial turnaround for the first half of 2026, with net revenue reaching R$ 181.9 million, a 172% increase compared to the same period in 2025. The pharmaceutical company achieved a net profit of R$ 11.5 million, reversing a previous loss of R$ 25.5 million. This growth was primarily driven by insulin sales, specifically Wosulin and Glargilin, and supply agreements with the Ministry of Health.

In separate news, Rede Soma Drogarias was named the ‘Top Pharmacy Association Network in Latin America 2026’ by Life Sciences Review. The award recognizes the association’s business model, which provides independent pharmacies with collective purchasing power, management technology, and operational support while allowing them to maintain their brand autonomy.